Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Flavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

New research suggests areas with higher concentrations of microplastics also have higher rates of chronic disease.

Compared to sugar, consuming sucralose—a widely used sugar substitute—increases activity in the hypothalamus, a brain region that regulates appetite and body weight, according to new USC research.

Experts explain what we know about the connection between gallstones and MASLD, and what you can do to reduce the risk of ...

COVID infection has been linked to a higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes.

Taking medications like Ozempic and Wegovy may lead to more hair loss than other weight loss drugs, new research found.

The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

vTv Therapeutics, a biopharmaceutical company based in High Point, has received clearance from the U.S. Food and Drug ...

Researchers found no significant increase in the prevalence of diabetes among American adults from 2013 to 2023.